HALO
Halozyme Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$110.21
−0.50%Price returns
Price only, unadjusted for dividends
- 1 day
- -0.5%
- 5 days
- +4.3%
- 1 month
- +31.5%
- 3 months
- +53.6%
- 6 months
- +63.1%
- Year to date
- +63.3%
- 1 year
- +46.7%
- 3 years
- +168.7%
- 5 years
- +155.9%
- 10 years
- +967.0%
Moving averages
- SMA 10 · Above
- $108
- Price vs SMA 10
- +1.6%
- SMA 50 · Above
- $91
- Price vs SMA 50
- +21.2%
- SMA 200 · Above
- $74
- Price vs SMA 200
- +48.1%
Relative strength
14-day RSI
- RSI 14-day
- 71.4
- RSI signal
- Overbought
Multi-period price returns, moving averages and the latest 14-day relative strength index · Data as of Jun 1, 2026